• Latest Posts

Themis Raises €40M for First Phase III Trial of a Chikungunya Vaccine 

Austrian Biotech Raises €19M to Commercialize First Chikungunya Vaccine

First Potential Vaccine for Chikungunya Virus Flies Through Phase II

No More Mosquito Bites? Targeting These Genes Could Prevent Future Outbreaks!

The Biggest Biotech News of 2017: What Happened This Year?

The Philippines Blocks Sanofi’s Dengue Vaccine for Safety Reasons


Austrian Biotech’s Vaccine Against Tropical Virus Moves Nicely Through Phase II

UPDATE: Austrian Biotech receives €3.3M boost for its Chikungunya Vaccine

In Depth 25 Jul 2017

Trouble in Paradise: How Biotech is Fighting Tropical Diseases

Startup Scout 23 Jun 2017

This Newly Founded French Biotech is All About Vaccines

Interview 21 Jun 2017

Video: Can Synbio Cure Malaria? – Fireside Chat with Oxitec’s CEO Hadyn Parry

New Results Show GM Mosquitoes Keep Dengue and Zika at Bay in Brazil